Resumo

TOBON T, Manuela et al. Adalimumab-induced cutaneous lupus. Rev.Colomb.Reumatol. [online]. 2016, vol.23, n.4, pp.271-274. ISSN 0121-8123.  https://doi.org/10.10167j.rcreu.2016.10.001.

Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.

Palavras-chave : Adalimumab; Cutaneous lupus erythematosus; Rheumatoid arthritis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )